Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$856M |
| 2 |
Meta Platforms (Facebook)
META
|
+$647M |
| 3 |
NVIDIA
NVDA
|
+$615M |
| 4 |
Berkshire Hathaway Class A
BRK.A
|
+$304M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$301M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.03B |
| 2 |
UnitedHealth
UNH
|
+$686M |
| 3 |
Tesla
TSLA
|
+$387M |
| 4 |
Abbott
ABT
|
+$380M |
| 5 |
Chevron
CVX
|
+$328M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.26% |
| 2 | Healthcare | 16.96% |
| 3 | Consumer Discretionary | 12.82% |
| 4 | Consumer Staples | 9.14% |
| 5 | Industrials | 9.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3426
Peraso
PRSO
$9.78M
| $124K | ﹤0.01% |
6,263
+5,575
| +810% | +$112K |
|
3427
Focus Universal
FCUV
$8.15M
| $123K | ﹤0.01% |
202
+171
| +552% | +$120K |
|
3428
Mexco Energy
MXC
$17.8M
| $123K | ﹤0.01% |
10,200
-1,200
| -11% | -$14K |
|
3429
Oramed Pharmaceuticals
ORMP
$167M
| $121K | ﹤0.01% |
33,700
+21,800
| +183% | +$69.9K |
|
|
PPTA
3430
Perpetua Resources
PPTA
$2.3B
| $121K | ﹤0.01% |
32,886
+18,786
| +133% | +$86.4K |
|
|
AIM
3431
AIM ImmunoTech
AIM
$7.03M
| $120K | ﹤0.01% |
1,790
+101
| +6% | +$4.87K |
|
3432
Antelope Enterprise Holdings
AEHL
$8.63M
| $119K | ﹤0.01% |
58
+48
| +480% | +$124K |
|
3433
OptimumBank Holdings
OPHC
$93.2M
| $119K | ﹤0.01% |
41,300
-3,900
| -9% | -$11.9K |
|
|
QNTM
3434
Quantum Biopharma Class B Subordinate Voting Shares
QNTM
$18.5M
| $118K | ﹤0.01% |
1,578
+516
| +49% | +$44.3K |
|
3435
Aptevo Therapeutics
APVO
$5.12M
| – | – |
0
| – | – |
|
3436
Data Storage Corp
DTST
$7.13M
| $117K | ﹤0.01% |
+50,401
| New | +$96.8K |
|
3437
Geospace Technologies
GEOS
$94.6M
| $117K | ﹤0.01% |
15,100
-10,600
| -41% | -$84.2K |
|
3438
Boxlight
BOXL
$2.03M
| $116K | ﹤0.01% |
291
+62
| +27% | +$28.8K |
|
|
CARV
3439
DELISTED
Carver Bancorp
CARV
| $116K | ﹤0.01% |
43,568
-7,208
| -14% | -$28.3K |
|
|
CLEU
3440
DELISTED
China Liberal Education Holdings
CLEU
| $116K | ﹤0.01% |
6
-3
| -33% | -$42.2K |
|
3441
DSS Inc
DSS
$5.39M
| $115K | ﹤0.01% |
15,988
+594
| +4% | +$2.61K |
|
3442
PDS Biotechnology
PDSB
$38.4M
| $115K | ﹤0.01% |
22,862
-342,875
| -94% | -$2.25M |
|
|
LBPH
3443
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
| $115K | ﹤0.01% |
+15,700
| New | +$119K |
|
3444
Vor Biopharma
VOR
$1.15B
| $112K | ﹤0.01% |
1,820
+400
| +28% | +$36.5K |
|
|
ZEPP
3445
Zepp Health
ZEPP
$66.4M
| $112K | ﹤0.01% |
24,550
-350
| -1% | -$1.76K |
|
3446
Bridgeline Digital
BLIN
$14.6M
| $111K | ﹤0.01% |
94,188
-49,656
| -35% | -$49.8K |
|
3447
IZEA Worldwide
IZEA
$60.6M
| $111K | ﹤0.01% |
46,025
+10,725
| +30% | +$28K |
|
|
SKE
3448
Skeena Resources
SKE
$3.3B
| $111K | ﹤0.01% |
+23,003
| New | +$135K |
|
3449
Dominari Holdings
DOMH
$57.4M
| $109K | ﹤0.01% |
37,326
+2,400
| +7% | +$7.25K |
|
|
CNTB
3450
Connect Biopharma Holdings
CNTB
$127M
| $108K | ﹤0.01% |
95,500
+6,400
| +7% | +$7.17K |
|
Similar funds
Renaissance Technologies's Q2 2023 Portfolio in Review
As of Q2 2023, Renaissance Technologies held 4,468 positions worth $69.4B, down 7.9% from $75.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies withdrew a net $8.1B in Q2 2023, closing 599 positions and reducing 1,691 holdings. Its most notable exit was UnitedHealth, an estimated $686M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Renaissance Technologies opened a new position in Berkshire Hathaway Class A worth $316M.
- Renaissance Technologies's largest Q2 2023 buy was Berkshire Hathaway Class A: 611 shares worth $316M.
- Renaissance Technologies added most to Apple in Q2 2023, an estimated $856M increase.
- Renaissance Technologies's biggest Q2 2023 reduction was Amazon, cutting an estimated $1.03B.
- Renaissance Technologies fully exited UnitedHealth in Q2 2023, selling an estimated $686M.
- Renaissance Technologies's ten largest holdings make up 12% of its $69.4B portfolio in Q2 2023.
- Renaissance Technologies opened 542 new positions and closed 599 in Q2 2023.
- Renaissance Technologies's portfolio value fell 7.9% quarter-over-quarter to $69.4B.
Based on Renaissance Technologies's 13F filing for Q2 2023, filed 11 Aug 2023.